Stock 0IVI VELOXIS PHARMACEUTICALS A/S
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Other languages Veloxis Pharmaceuticals A/S CBOE EUROPE EQUITIES

Equities

0IVI

DK0060048148

End-of-day quote CBOE EUROPE EQUITIES
Other stock markets
- DKK - Intraday chart for Veloxis Pharmaceuticals A/S
05-30 Veloxis Pharmaceuticals A/S Selects to Present At the 2024 American Transplant Congress in Philadelphia CI
2022 Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD) CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Veloxis Pharmaceuticals A/S Selects to Present At the 2024 American Transplant Congress in Philadelphia
Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)
Scandion Oncology A/S : appoints Johnny Stilou as new CFO
Veloxis Pharmaceuticals, Inc entered into a global license agreement to acquire Worldwide Rights to FR104 from OSE Immunotherapeutics SA.
Veloxis Pharmaceuticals A/S : Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020
Veloxis Pharmaceuticals A/S Announces Board Appointments
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from OMX Nordic All-Share Index
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
Veloxis Pharmaceuticals A/S : Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S
Veloxis Pharmaceuticals A/S : - Notice to Convene Extraordinary General Meeting
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications
Veloxis Pharmaceuticals A/S : Notice to Convene Extraordinary General Meeting
Veloxis Pharmaceuticals A/S : Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S: Major Shareholder Notifications
Veloxis Pharmaceuticals A/S : Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VELO Stock
  4. 0IVI Stock
  5. News Veloxis Pharmaceuticals A/S
  6. Other languages